A recent report from Deloitte, described by The Wall Street Journal, predicts mergers and acquisitions will accelerate in 2017, following an uptick in Q4 2016. Among principal reasons are acquisition of technology and convergence across healthcare, life sciences and pharma.
The report covers a 2016 year-end survey of 1,000 corporate executives and private equity investors and ties an interest in acquiring technology assets to industry consolidation. This has been the experience of one of our clients, acquired for its technology in November in the highly fragmented digital health industry.
Assuming a convergence in healthcare, life sciences and pharma and anticipated regulatory change, each identified in the report as a factor, owners of independent digital health companies may see increased opportunities to exit.
Other technology focused businesses may also benefit from more opportunities.